Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Kassala, Sudan | OTHER |
| Kassala | UNKNOWN |
| Sudan | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Intravenous artesunate is egual to quinine in the treatment of severe malaria
Intravenous artesunate is egual to quinine in the treatment of severe malaria in the form of fever clearance time and parasite clearance time
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| artesunate | Experimental | intravenous artesunate 80 mg/kg initially then after 8 hours then daily |
|
| quinine | Active Comparator | quinine infusion 80 mg/kg every 8 hours |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| artesunate | Drug | intravenous artesunate 80 mg/kg initially then after 8 hours then daily |
|
| Measure | Description | Time Frame |
|---|---|---|
| clearance of the parasite and fever | To compare the parasite clearance time and fever clearance time between the two groups | 3 days |
Not provided
Not provided
Inclusion Criteria:
severe P.falciparum malaria-
Exclusion Criteria:
mixed infection Pregnant women -
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kassala | Recruiting | Kassala | Kassala | 249 | Sudan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20850004 | Background | Eltahir HG, Omer AA, Mohamed AA, Adam I. Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2010 Oct;104(10):684-6. doi: 10.1016/j.trstmh.2010.05.009. Epub 2010 Jun 17. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008288 | Malaria |
| D008224 | Lymphoma, Follicular |
| ID | Term |
|---|---|
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D007239 | Infections |
| D000096724 | Mosquito-Borne Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077332 | Artesunate |
| D011803 | Quinine |
| ID | Term |
|---|---|
| D037621 | Artemisinins |
| D017382 | Reactive Oxygen Species |
| D005609 | Free Radicals |
| D007287 | Inorganic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Quinine | Drug | quinine infusion 80 mg/kg every 8 hours till the patient can take orally |
|
| D000079426 |
| Vector Borne Diseases |
| D008228 | Lymphoma, Non-Hodgkin |
| D008223 | Lymphoma |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D009930 |
| Organic Chemicals |
| D012717 | Sesquiterpenes |
| D013729 | Terpenes |
| D006838 | Hydrocarbons |
| D002930 | Cinchona Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D011812 | Quinuclidines |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D011804 | Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |